SupplySide Global 2025 live: Gencor rebrands as Saanroo in “new era” of science-backed nutrition

After a quarter-century in the nutraceutical and pharmaceutical industries, Gencor reveals it is entering a new chapter as Saanroo, a name and identity that the company says reflects both heritage and forward-looking vision. The rebrand is meant to underscore its commitment to delivering science-backed, evidence-driven wellness solutions across nutraceuticals, beauty, healthcare, and functional nutrition.

Live at SupplySide Global in Las Vegas, Nevada, US (October 28–29), Nutrition Insight sits down with Ramasamy Venkatesh, Saanroo’s managing director and co-founder, and John Quilter, the company’s CEO, to understand the nutraceutical player’s rebrand.

“Our history has been very strong in pharmaceuticals since the late 90s, and as our business has developed over the last 25 years, we felt it was the right time to put in a global, dedicated nutra business unit represented by Saanroo,” Quilter says. 

The name Saanroo draws from the Tamil word “sanru” (சான்று), which the company states means “proof, testimony, or evidence.”

“Why we talk about the word proven is because we have had a huge commitment in our history to science, and we have invested significantly in over 50-plus clinical studies to prove the efficacy of our ingredients,” says Quilter. “We feel this is a very exciting time to go to market with our new dedicated business.”

Venkatesh explains that Gencor is a healthcare group that encompasses pharmaceutical and nutraceutical divisions. The company’s nutraceutical success comes from applying a pharmaceutical model and conducting years of research and evidence gathering before commercialization.

“In the nutraceutical segment, which is the fastest growing in the world, we set the standard in terms of evidence-based ingredients, and that prompted us to have the whole nutraceutical sector worldwide rebranded as Saanroo,” he underscores. “Gencor will stay as the name for the pharmaceutical side — this way, we separate the pharmaceutical side and nutraceutical side of the business, and each one has its own distinct identity.”

From research to real results

The company’s new infinity-shaped “S” logo, which is formed by interconnected molecular dots, and has a blue, green, and yellow palette.

Venkatesh emphasizes that the company’s history reflects its continuous research and innovation, with multiple clinical studies conducted for each ingredient. Rather than relying on a single trial, he says Saanroo repeatedly validates findings to deepen the understanding of an ingredient’s mechanisms of action, and invests in demonstrating clear, evidence-based results that show how and why their nutraceutical ingredients work.

“We don’t just give a product saying it works,” he adds. “We prove it in every area, right from the basic research, to the biomarkers, and to the clinical studies, and showing this logical progression of our science validates every step, similar to what the pharmaceutical industry does.”

Quilter says that customers expect comprehensive proof, and Saanroo delivers through rigorous in vitro, animal, and human studies to produce validated, evidence-based results throughout an ingredient’s development.

“Venkatesh has led the drive around our science,” he stresses. We have invested in excess of US$15 million in clinical studies, and we have completed over 50 studies.”

“Underneath Saanroo is our tagline, which is ‘wellness proven.’ Proof is a keyword, not just a promise.”

Saanroo’s four pillars of wellness

Quilter also highlights the newly rebranded company’s priorities consisting of four health pillars for Saanroo: men’s health, women’s health, longevity, and advanced delivery system technology. 

In terms of current innovations, he notes that the company is launching two technology innovations at the trade show. One is called BioBerb, which uses its advanced delivery system called Lipisperse. The ingredient is wrapped around the Berberine to make it more bioavailable . The ingredient aids in metabolic health. 

In addition to that, Saanroo will introduce Trpti — an innovative topical liposomal delivery system featuring oleoylethanolamide (OEA) as its active ingredient. Quilter says this plays into the space that’s been developing in the US around the GLP-1 topic and around microbiome modulation.

“I’ve been working on Trpti for eight years,” Venkatesh underscores. It’s a fatty acid that is endogenously produced by your body, and it is produced in response to feeding and eating. It is a primary driver for the production and release of GLP-1 in the body.”

Future focuses

We’re conducting multiple clinical studies across cardiovascular and metabolic health, female libido, and fertility — addressing key challenges in women’s wellness today.

“There’s a whole range of areas that we are doing which relate to the four pillars,” Venkatesh concludes. “We’re doing a lot of work on the microbiome, because we believe that the gut-brain axis is what drives the body, and most of your good and bad things come from your gut health in the body. In the future, Saanroo will focus a lot on gut health.”